Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty
- PMID: 38467650
- PMCID: PMC10928067
- DOI: 10.1038/s41598-024-54916-x
Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty
Abstract
Preventing avoidable venous-thrombo-embolism (VTE) is a priority to improve patient and service outcomes after total hip and total knee arthroplasty (THA, TKA), but compliance with relevant clinical guidelines varies. This study aims to determine the degree to which prophylaxis was compliant with Australian Orthopaedic Association (AOA) VTE prophylaxis guidelines and whether non-compliance is associated with increased risk of VTE. A prospective multi-centre cohort study of adults with osteoarthritis undergoing primary TKA/THA was completed at 19 high-volume public and private hospitals. Data were collected prior to surgery and for one-year post-surgery. Logistic regression was undertaken to explore associations between non-compliance with AOA VTE prophylaxis guidelines and symptomatic 90-day VTE outcomes. Data were analysed for 1838 participants from 19 sites. The rate of non-compliance with all clinical guideline recommendations was 20.1% (N = 369), with 14.1% (N = 259) non-compliance for risk-stratified prophylaxis, 35.8% (N = 658) for duration, and 67.8% (N = 1246) for other general recommendations. Symptomatic VTE was experienced up to 90-days post-surgery by 48 people (2.6%). Overall guideline non-compliance (AOR = 0.93, 95%CI = 0.4 to 1.3, p = 0.86) was not associated with a lower risk of symptomatic 90-day VTE. Results were consistent when people with high bleeding risk were excluded (AOR = 0.94, 95%CI = 0.44 to 2.34, p = 0.89). Non-compliance with the AOA VTE prophylaxis guidelines was not associated with risk of 90-day VTE after arthroplasty. This counterintuitive finding is concerning and necessitates a rigorous review of the AOA VTE prevention clinical guideline.
Keywords: Clinical guidelines; Primary total hip arthroplasty; Primary total knee arthroplasty; Prophylaxis; Surgical complications; Venous thromboembolism.
© 2024. The Author(s).
Conflict of interest statement
IA is the scientific secretary of the AOA. JF is an unpaid member of the group that developed the NHMRC Guidelines for the prevention of VTE. All other declare no potential conflict of interest.
Figures
References
-
- Suen K, Westh RN, Churilov L, Hardidge AJ. Low-molecular-weight heparin and the relative risk of surgical site bleeding complications: Results of a systematic review and meta-analysis of randomized controlled trials of venous thromboprophylaxis in patients after total joint arthroplasty. J. Arthroplast. 2017;32:2911–2919.e2916. doi: 10.1016/j.arth.2017.04.010. - DOI - PubMed
-
- AOA Arthroplasty Society of Australia. Guidelines for VTE prophylaxis for hip and knee arthroplasty. https://arthroplasty.org.au/wp-content/uploads/2024/01/asa-guidelines-fo... (2018).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
